Structure Therapeutics Inc.
GPCR | NASDAQ
$36.49
-$0.32 (-0.87%)
Sep 22, 2026, 2:42 PM ET · Market open
Market Data
Market Cap $2.12B
Enterprise Value $782.6M
Beta -1.52
Average Volume 740.15K
Shares Outstanding (Diluted) 72.65M
Shares Change YoY 25.44%
Institutional Ownership 92.10%
Exchange NASDAQ
ISIN US86366E1064
Price Performance
Price Change 1M -24.4%
Price Change 3M -19.3%
Price Change 6M -23.5%
Price Change YTD -46.0%
Price Change 1Y 50.5%
Price Change 3Y 8.3%
Price Change 5Y 41.6%
1M CAGR (ann.) -30.7%
1Y CAGR (ann.) 58.5%
5Y CAGR (ann.) N/A
All-Time CAGR 10.0%
Valuation
PE Ratio -12.15
Forward PE N/A
PEG Ratio 0.86
Forward PEG -0.42
PS Ratio N/A
Forward PS 46,618.20
PB Ratio 1.56
P/FCF Ratio -10.07
P/Adj. FCF Ratio -8.09
P/OCF Ratio -12.15
EV/Sales N/A
EV/EBIT -3.65
EV/EBITDA -3.68
EV/FCF -3.72
Earnings Yield -8.2%
FCF Yield -9.9%
Adj. FCF Yield -12.4%
Financial Health
Net Cash $1.34B
Total Debt $6.23M
Cash & Short-Term Investments $1.34B
Total Assets $1.43B
Current Ratio 20.75
Quick Ratio 20.75
Debt / Equity Ratio 0.00
Debt / EBITDA -0.03
Debt / FCF -0.03
OCF / Debt -32.92
Interest Coverage 0.00
Altman Z-Score 17.87
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -24.5%
Returns
Return on Assets -15.1%
Return on Equity -16.9%
Return on Invested Capital -18.9%
Return on Capital Employed -19.0%
Return on Tangible Assets -15.1%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -13.3%
EPS CAGR 5Y -16.8%
EPS CAGR 10Y N/A
FCF CAGR 3Y -32.8%
FCF CAGR 5Y -45.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 14
EPS Growth Next 3Y 32.9%
Revenue Growth Next 3Y N/A
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.33
EPS Growth Est (next Q) -12.2%
Revenue Est (next Q) $50M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $90.50
Price Target Upside 145.9%
Cash Flow
Operating Cash Flow $-205.01M
Free Cash Flow $-210.41M
Adj. Free Cash Flow $-261.88M
FCF Per Share -$3.09
OCF Per Share -$3.03
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-1.22M
Operating Income $-258.07M
EBITDA $-212.44M
Net Income $-215.06M
EPS (Diluted) -$3.03
Revenue / Employee N/A
Profit / Employee $-765.34K
Employees 281
Add to Watchlist
Select watchlists to add or remove GPCR